“…Fibrin degradation (fibrinolysis) is mainly regulated by the cell surface-associated plasmin, which is a complex of soluble plasminogen and plasminogen activators [ 90 , 95 ]. On the basis of the degradation mechanism, fibrinolysis may be the key player in the temporal and spatial arrangement to promote bone tissue regeneration and tissue infiltration into defects [ 96 , 97 , 98 ]. Therefore, controllable biodegradability and biological compatibility have practical potential for both 3D scaffolds and the characterization biopolymers for drug delivery systems with additional biologics, such as cells, enzymes, and growth factors, in order to promote hard tissue regeneration [ 99 , 100 , 101 ].…”